Impact of Biologic Agents With and Without Concomitant Methotrexate and at Reduced Doses in Older Rheumatoid Arthritis Patients

Publisher： John Wiley & Sons Inc

E-ISSN： 2151-4658|67|5|624-632

ISSN： 2151-464x

Source： ARTHRITIS CARE AND RESEARCH, Vol.67, Iss.5, 2015-05, pp. : 624-632

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mixed treatment comparison of efficacy and tolerability of biologic agents in patients with rheumatoid arthritis

By Hochberg Marc C.   Berry Scott   Broglio Kristine   Rosenblatt Lisa   Nadkarni Anagha   Trivedi Digisha   Hebden Tony  

Current Medical Research and Opinion, Vol. 29, Iss. 10, 2013-10 ,pp. : 1213-1222

Informa Healthcare

Access to resources Recommend Favorite

Comparison of different biologic agents in patients with rheumatoid arthritis after failure of the first biologic therapy

By Strehblow Christoph  

Wiener Medizinische Wochenschrift, Vol. 160, Iss. 9-10, 2010-05 ,pp. : 225-229

Springer Publishing Company

Access to resources Recommend Favorite

Effects of Concomitant Methotrexate on Large Joint Replacement in Patients With Rheumatoid Arthritis Treated With Tumor Necrosis Factor Inhibitors: A Multicenter Retrospective Cohort Study in Japan

By  

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 10, 2015-10 ,pp. : 1363-1370

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of Concomitant Methotrexate on Large Joint Replacement in Patients With Rheumatoid Arthritis Treated With Tumor Necrosis Factor Inhibitors: A Multicenter Retrospective Cohort Study in Japan

By  

ARTHRITIS CARE AND RESEARCH, Vol. 2151-464X, Iss. 10, 2015-10 ,pp. : 1363-1370

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment With Anti–Tumor Necrosis Factor Biologic Agents in Human T Lymphotropic Virus Type I–Positive Patients With Rheumatoid Arthritis

By  

ARTHRITIS CARE AND RESEARCH, Vol. 66, Iss. 5, 2014-05 ,pp. : 788-792

John Wiley & Sons Inc

Access to resources Recommend Favorite